Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
gptkb:guadecitabine
|
| gptkbp:CASNumber |
929904-94-9
|
| gptkbp:chemicalClass |
antiviral drug
|
| gptkbp:clinicalTrialPhase |
Phase III
|
| gptkbp:developedBy |
gptkb:Astex_Pharmaceuticals
|
| gptkbp:hasMolecularFormula |
C15H20N4O7S
|
| https://www.w3.org/2000/01/rdf-schema#label |
SGI-110
|
| gptkbp:indication |
gptkb:acute_myeloid_leukemia
myelodysplastic syndromes |
| gptkbp:mechanismOfAction |
DNA methyltransferase inhibitor
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL2105727
25154816 |
| gptkbp:relatedTo |
gptkb:decitabine
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:status |
investigational drug
|
| gptkbp:UNII |
2XU8E8E8YK
|
| gptkbp:bfsParent |
gptkb:Astex_Therapeutics
|
| gptkbp:bfsLayer |
6
|